Sinovac Files to Begin Trials of H7N9 Avian Flu Vaccine

Sinovac Biotech has submitted a Clinical Trial Application with the CFDA to begin clinical trials of its avian flu A(H7N9) vaccine. The CFDA accepted the filing today. An outbreak of the H7N9 virus was ended last spring by aggressive action that shut down live poultry markets, but now the virus has returned. So far this year, 96 reported cases of H7N9 flu have caused 20 deaths in China. Once again, poultry markets have been ordered to close in Hong Kong, Shanghai and many other cities. More details.... Stock Symbol: (NSDQ: SVA) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.